Global Hepatitis A Vaccine Market Size study, by Product Type (Inactivated vaccine and Live attenuated vaccine) Application (Government Institution, Private Sector and Other) and Regional Forecasts 2020-2027

BIZ4355422
200 Pages
May 2021
Pharmaceuticals

Download Sample Get Discount

Global Hepatitis A Vaccine Market is valued approximately at USD 672.21 million in 2019 and is anticipated to grow with a growth rate of more than 2.1% over the forecast period 2020-2027. The Hepatitis A vaccine is a hepatitis A prevention vaccine. The disease is a hepatitis A virus-induced liver condition that results from moderate to serious disease. The growing prevalence of hepatitis A around the globe is a significant factor behind the rising demand for hepatitis A vaccinations, contributing to increasing vaccination drives. As per the Center for Disease Control, a total of 12,474 cases of hepatitis A were identified in the US in 2018 and the organization projected the real number of reprocessed cases in the year at 24,900 due to the undiagnosed cases. In addition, the rise in the number of cases of Hepatitis A prompts national governments and health agencies to take action to raise awareness of the disease and manage vaccine campaigns in risk-prone areas. This has encouraged policymakers to increase their awareness, identification, support and vaccine campaigns. As per the World Health Organization, as of May 2019, a total of 34 countries worldwide have used or intended the use of the Hepatitis A vaccine in regular immunization of children in particular risk categories. However, lack of awareness among population impedes the growth of the market over the forecast period of 2020-2027.

The regional analysis of global Hepatitis A Vaccine market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region across the world in terms of market share as in China, the live attenuated Hepatitis A Vaccine is becoming a favorable element to tackle the disease. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rise in pediatric population and increase in awareness about vaccination, results in increasing demand for Hepatitis A Vaccine in emerging economies, such as India and China would create lucrative growth prospects for the Hepatitis A Vaccine market across Asia-Pacific region.

Major market player included in this report are:

GlaxoSmithKline

Merck & Co. Inc.

Sanofi SA

Sinovac Biotech

Zhejiang Pukang Biotechnology Co., Ltd.

Changchun Institute of Biological Products Co., Ltd.

KM Biologics

IMBCA

ChangSheng Bio-Technology Co., Ltd

Convac Ltd

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Inactivated vaccine

Live attenuated vaccine

By Application:

Government Institution

Private Sector

Other

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Hepatitis A Vaccine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. Hepatitis A Vaccine Market, by Region, 2018-2027 (USD Billion)

1.2.2. Hepatitis A Vaccine Market, by Product Type, 2018-2027 (USD Billion)

1.2.3. Hepatitis A Vaccine Market, by Application, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Hepatitis A Vaccine Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Hepatitis A Vaccine Market Dynamics

3.1. Hepatitis A Vaccine Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Hepatitis A Vaccine Market: Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economic

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Hepatitis A Vaccine Market, by Product Type

5.1. Market Snapshot

5.2. Global Hepatitis A Vaccine Market by Product Type, Performance - Potential Analysis

5.3. Global Hepatitis A Vaccine Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)

5.4. Hepatitis A Vaccine Market, Sub Segment Analysis

5.4.1. Inactivated vaccine

5.4.2. Live attenuated vaccine

Chapter 6. Global Hepatitis A Vaccine Market, by Application

6.1. Market Snapshot

6.2. Global Hepatitis A Vaccine Market by Application, Performance - Potential Analysis

6.3. Global Hepatitis A Vaccine Market Estimates & Forecasts by Application 2017-2027 (USD Billion)

6.4. Hepatitis A Vaccine Market, Sub Segment Analysis

6.4.1. Government Institution

6.4.2. Private Sector

6.4.3. Other

Chapter 7. Global Hepatitis A Vaccine Market, Regional Analysis

7.1. Hepatitis A Vaccine Market, Regional Market Snapshot

7.2. North America Hepatitis A Vaccine Market

7.2.1. U.S. Hepatitis A Vaccine Market

7.2.1.1. Product Type breakdown estimates & forecasts, 2017-2027

7.2.1.2. Application breakdown estimates & forecasts, 2017-2027

7.2.2. Canada Hepatitis A Vaccine Market

7.3. Europe Hepatitis A Vaccine Market Snapshot

7.3.1. U.K. Hepatitis A Vaccine Market

7.3.2. Germany Hepatitis A Vaccine Market

7.3.3. France Hepatitis A Vaccine Market

7.3.4. Spain Hepatitis A Vaccine Market

7.3.5. Italy Hepatitis A Vaccine Market

7.3.6. Rest of Europe Hepatitis A Vaccine Market

7.4. Asia-Pacific Hepatitis A Vaccine Market Snapshot

7.4.1. China Hepatitis A Vaccine Market

7.4.2. India Hepatitis A Vaccine Market

7.4.3. Japan Hepatitis A Vaccine Market

7.4.4. Australia Hepatitis A Vaccine Market

7.4.5. South Korea Hepatitis A Vaccine Market

7.4.6. Rest of Asia Pacific Hepatitis A Vaccine Market

7.5. Latin America Hepatitis A Vaccine Market Snapshot

7.5.1. Brazil Hepatitis A Vaccine Market

7.5.2. Mexico Hepatitis A Vaccine Market

7.6. Rest of The World Hepatitis A Vaccine Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. GlaxoSmithKline

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Merck & Co. Inc.

8.2.3. Sanofi SA

8.2.4. Sinovac Biotech

8.2.5. Zhejiang Pukang Biotechnology Co., Ltd.

8.2.6. Changchun Institute of Biological Products Co., Ltd.

8.2.7. KM Biologics

8.2.8. IMBCA

8.2.9. ChangSheng Bio-Technology Co., Ltd

8.2.10. Convac Ltd

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Hepatitis A Vaccine market, report scope

TABLE 2. Global Hepatitis A Vaccine market estimates & forecasts by Region 2017-2027 (USD Billion)

TABLE 3. Global Hepatitis A Vaccine market estimates & forecasts by Product Type 2017-2027 (USD Billion)

TABLE 4. Global Hepatitis A Vaccine market estimates & forecasts by Application 2017-2027 (USD Billion)

TABLE 5. Global Hepatitis A Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 6. Global Hepatitis A Vaccine market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 7. Global Hepatitis A Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 8. Global Hepatitis A Vaccine market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 9. Global Hepatitis A Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 10. Global Hepatitis A Vaccine market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 11. Global Hepatitis A Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 12. Global Hepatitis A Vaccine market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 13. Global Hepatitis A Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 14. Global Hepatitis A Vaccine market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 15. U.S. Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 16. U.S. Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 17. U.S. Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 18. Canada Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 19. Canada Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 20. Canada Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 21. UK Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 22. UK Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 23. UK Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 24. Germany Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 25. Germany Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 26. Germany Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 27. RoE Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 28. RoE Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 29. RoE Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 30. China Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 31. China Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 32. China Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 33. India Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 34. India Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 35. India Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 36. Japan Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 37. Japan Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 38. Japan Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 39. RoAPAC Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 40. RoAPAC Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 41. RoAPAC Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 42. Brazil Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 43. Brazil Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 44. Brazil Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 45. Mexico Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 46. Mexico Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 47. Mexico Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 48. RoLA Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 49. RoLA Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 50. RoLA Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 51. Row Hepatitis A Vaccine market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 52. Row Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 53. Row Hepatitis A Vaccine market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 54. List of secondary sources, used in the study of global Hepatitis A Vaccine market

TABLE 55. List of primary sources, used in the study of global Hepatitis A Vaccine market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Hepatitis A Vaccine Market Size study, by Product Type (Inactivated vaccine and Live attenuated vaccine) Application (Government Institution, Private Sector and Other) and Regional Forecasts 2020-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara